Spectrophotometric determination of silicon in ultrapure, dilute hydrofluoric acid solutions

A new analytical procedure is described for the spectrophotometric determination of silicon in ultrapure, dilute hydrofluoric acid (HF) solutions. The method is a variation of the classical molybdenum blue method, but adds optimised quantities of boric acid to eliminate any HF interference in the colorimetric process. Its sensitivity and detection limit have been evaluated as, respectively, (180 ± 9) · 10^− 5/(μg/L Si) and 7.6 μg/L Si, and its reproducibility has been confirmed. The method has also been successfully applied and validated for the determination of the etch rate of single crystalline silicon surfaces in ultrapure 2% v/v HF solutions.     

Aspects of auditing in clinical laboratories

Quality and patient safety are terms that both providers and recipients of healthcare are very familiar with. Accreditation is another term that is closely linked to quality and patient safety. Audit is a systematic, independent, and documented process for obtaining evidence and evaluating it objectively to determine the extent to which audit criteria are fulfilled. Accreditation and audit are integral components of the same process. Three different types of audit are well recognized—internal, external, and co-operative. Reading of relevant documents, observation of laboratory practices, and asking open-ended probing questions are important auditing techniques. For auditing to be successful, experienced, qualified, and well trained auditors are essential. Furthermore, the auditor should be open-minded, not prejudiced, a team player and effective communicator, both in writing and verbally. In many instances, the emphasis for seeking laboratory accreditation has shifted from building quality systems—to produce reliable results and ensure patient safety—to just passing the inspection. Recently, the emphasis for laboratory quality improvement has been placed on pre and post-analytical processes in preference to analytical quality. The analytical quality of laboratory results is still far from ideal and it may be detrimental if less emphasis is placed on this aspect of laboratory medicine. Auditing or on-site inspection as a regulatory tool does not work or present a realistic picture of laboratory quality. A continuous quality improvement approach will help laboratories to build quality into their systems. Presented at the Conference “Excellence in Laboratory Medicine”, November 2007, Al Ain, United Arab Emirates.     

Rh-N-heterocyclic carbene (NHC) complex-catalyzed addition of phenylboronic acid to N-sulfonyl and N-phosphinoyl aldimines

Rh-N-heterocyclic carbene (NHC) complexes were generated in situ from imidazolium salts, [RhCl(cod)](2) and t-BuOK in dioxane. In the presence of a catalytic amount of Rh-NHC complexes, the addition reaction of phenylboronic acid to N-sulfonylarylimines and N-phosphinyolarylimines gave the corresponding amines in high yields.     

Targeted Delivery of Anticancer Drug Loaded Charged PLGA Polymeric Nanoparticles Using Electrostatic Field

Pure positive electrostatic charges (PPECs) show suppressive effect on the proliferation and metabolism of invasive cancer cells without affecting normal tissues. PPECs are used for the delivery of drug-loaded polymeric nanoparticles (DLNs) capped with negatively charged poly(lactide-co-glycolide) (PLGA) and Poly(vinyl-alcohol) PVA into the tumor site of mouse models. The charged patch is installed on top of the skin in the mouse models' tumor region, and the controlled selective release of the drug is assayed by biochemical, radiological, and histological experiments on both tumorized models and normal rats' livers. It is found that DLNs synthesized by PLGA show great attraction to PPECs due to their stable negative charges, which would not degrade immediately in blood. The burst and drug release after less than 48h of this synthesized DLNs are 10% and 50%, respectively. These compounds can deliver the loaded-drug into the tumor site with the assistance of PPECs, and the targeted-retarded release will take place. Hence, local therapy can be achieved with much lower drug concentration (conventional chemotherapy [2 mg kg⁻¹] versus DLNs-based chemotherapy [0.75 mg kg⁻¹]) with negligible side effects in non-targeted organs. PPECs have many potential clinical applications for advanced-targeted chemotherapy with the lowest discernible side effects.     

Determination of Fenofibric Acid in Human Plasma by LC–MS/MS and LC–UV

A sensitive, high-throughput and economic liquid chromatographic method for determination of fenofibric acid in human plasma was developed and validated by ultraviolet detection and tandem mass spectrometry, then applied in pharmacokinetic study to investigate Lipanthyl™ 200 mg MC bioavailability under food and fasting conditions. Fenofibric acid with 2-chloro fenofibric acid-d6 (internal standard) was extracted from 100 µL of human plasma by acetonitrile in a single extraction step. 25 and 2 µL from supernatant were injected onto ACE column, 50 mm, 5 micron with 4.6 mm inner diameter for LC–UV and 2.1 mm for LC–MS/MS, and both systems were eluted isocratically by water:methanol:formic acid (35:65:0.1, v/v/v), with a constant flow rate of 1 mL min⁻¹. The established calibration curve was linear between 0.05–20 µg mL⁻¹, and the within- and between-day precisions were all below 13 % in both LC–MS/MS and LC–UV systems during validation, and accuracies ranged between 91 and 112 %. Twenty-eight healthy adult subjects participated in this clinical study, and the pharmacokinetic parameters including coefficient of variation were calculated and discussed. A dramatic decrease in C _max and AUC0-72 (3.63- and 1.85-fold, respectively) were observed for Lipanthyl™ MC under fasting conditions with more variable inter subject measurements comparing to the fed state.

     

Low temperature pyrolysis of carboxymethylcellulose

Unlike the common high temperature pyrolysis of carboxymethylcellulose (CMC) targeting activated carbon, this study investigates the pyrolytic behaviour of plain CMC at low temperatures ranging between 260 and 300 °C. Preliminary experiments were conducted using differential scanning calorimetry to define the temperature range necessary for the process. Low-temperature pyrolysis was then simulated using thermogravimetric analysis under inert atmosphere. Investigations reveal that a minimum holding temperature of 260 °C is required for an isothermal process, at which pyrolysis is terminated after around 26 min. Increasing exposure temperature reduces pyrolysis time. Within the range of the investigated sample and CMC particle size, no significant effects could be measured regarding the decomposition behaviour. The resulting char was further analysed using X-ray diffraction and Fourier transform infrared spectroscopy. Visual inspection was conducted using scanning electron microscopy. Upon pyrolysis, originally longitudinally shaped CMC was found to be converted into spherical particles of functionalised amorphous carbon with an average particle size of 41 µm.     

The skeletal rearrangement of gold- and platinum-catalyzed cycloisomerization of cis-4,6-dien-1-yn-3-ols: pinacol rearrangement and formation of bicyclo[4.1.0]heptenone and reorganized styrene derivatives

With gold and platinum catalysts, cis-4,6-dien-1-yn-3-ols undergo cycloisomerizations that enable structural reorganization of cyclized products chemoselectively. The AuCl3-catalyzed cyclizations of 6-substituted cis-4,6-dien-1-yn-3-ols proceeded via a 6-exo-dig pathway to give allyl cations, which subsequently undergo a pinacol rearrangement to produce reorganized cyclopentenyl aldehyde products. Using chiral alcohol substrates, such cyclizations proceed with reasonable chirality transfer. In the PtCl2-catalyzed cyclization of 7,7-disubstituted cis-4,6-dien-1-yn-3-ols, we obtained exclusively either bicyclo[4.1.0]heptenones or reorganized styrene products with varied substrate structures. On the basis of the chemoselectivity/structure relationship, we propose that bicyclo[4.1.0]heptenone products result from 6-endo-dig cyclization, whereas reorganized styrene products are derived from the 5-exo-dig pathway. This proposed mechanism is supported by theoretic calculations.     

Enhanced skin permeation of diclofenac by ion-pair formation and further enhancement by microemulsion

Enhancement of skin permeability of anionic diclofenac from non-aqueous vehicle isopropyl myristate (IPM) by ion-pair formation with either alkylamines or benzylamine as model cationic ions was examined in guinea pig dorsal skin. Diclofenac ion flux increased in the presence of these amines due to an increase in solubility. Maximum flux was observed in the presence of n-hexylamine, which induced 7.3-fold increase accompanied by a 45-fold increase in solubility. Permeability coefficients of the ionic form of diclofenac in the presence of benzylamine, n-hexylamine and iso-octylamine as counter ions in IPM were larger than those of the non-ionic form of diclofenac. Since the solubility of diclofenac was still limited, to obtain further enhancement of skin permeation, the effects of microemulsions as a vehicle consisting of phosphate buffered saline (PBS), isopropyl myristate (IPM), polyoxyethylene sorbitan monooleate (Tween 80) and ethanol were examined for transport of diclofenac-benzylamine ion-pairs. All microemulsion formulations tested increased diclofenac flux 4.9-fold to 10.7-fold over the value without a microemulsion accompanied by a 217-fold to 302-fold improvement in the solubility of diclofenac-benzylamine ion-pairs, but permeability coefficients were decreased 28-44 fold. Maximum enhancement was observed for a microemulsion with a ratio of PBS, IPM, ethanol and Tween 80 of 25 : 8 : 47 : 20 (w/w). The present findings suggest the usefulness of combined use of ion-pairs with microemulsions for enhancement of skin permeation of ionic drugs.     

Determination of pesticides in water by cone-shaped membrane protected liquid phase microextraction prior to micro-liquid chromatography

A new sample pre-treatment technique termed cone-shaped membrane liquid phase microextraction (CSM-LPME) was developed and combined with micro-liquid chromatography (micro-LC) for the determination of selected pesticides in water samples. Four pesticides (hexaconazole, procymidone, quinalphos and vinclozolin) were considered as target analytes. Several important extraction parameters such as types of extraction solvent, agitation rate, pH value, total exposure time and effect of salt and humic acids were optimized. Enrichment factors of > 50 folds were easily achieved within 20 min of extraction. The analytical data demonstrated relative standard deviations for the reproducibility of the optimized CSM-LPME method ranging from 6.3 to 7.5%. The correlation coefficients of the calibration curves were at least 0.9995 across a concentration range of 2-100 microg/L. The detection limits for all the analytes were found to be in the range of 1.1-1.9 microg/L.